VioQuest Pharmaceuticals Performance
| VOQPDelisted Stock | USD 0 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and VioQuest Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days VioQuest Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, VioQuest Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Total Cashflows From Investing Activities | 1.7 M | |
| Discontinued Operations | -263.7 K |
VioQuest |
VioQuest Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.30 in VioQuest Pharmaceuticals on November 13, 2025 and sell it today you would earn a total of 0.00 from holding VioQuest Pharmaceuticals or generate 0.0% return on investment over 90 days. VioQuest Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than VioQuest, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VioQuest Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of VioQuest Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for VioQuest Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| VioQuest Pharmaceuticals is not yet fully synchronised with the market data | |
| VioQuest Pharmaceuticals has some characteristics of a very speculative penny stock | |
| VioQuest Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.41, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist VioQuest Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, VioQuest Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VioQuest Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VioQuest to invest in growth at high rates of return. When we think about VioQuest Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (10.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| VioQuest Pharmaceuticals currently holds about 814.48 K in cash with (7.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
VioQuest Pharmaceuticals Fundamentals Growth
VioQuest Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of VioQuest Pharmaceuticals, and VioQuest Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VioQuest Pink Sheet performance.
| Return On Asset | -1.25 | |||
| Current Valuation | 163.85 K | |||
| Price To Sales | 0.60 X | |||
| EBITDA | (6.84 M) | |||
| Cash And Equivalents | 814.48 K | |||
| Cash Per Share | 0.17 X | |||
| Book Value Per Share | (1.16) X | |||
| Cash Flow From Operations | (7.08 M) | |||
| Earnings Per Share | (2.24) X | |||
| Total Asset | 1.36 M | |||
| Retained Earnings | (44.35 M) | |||
| Current Asset | 1.13 M | |||
| Current Liabilities | 2.69 M | |||
About VioQuest Pharmaceuticals Performance
Assessing VioQuest Pharmaceuticals' fundamental ratios provides investors with valuable insights into VioQuest Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the VioQuest Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey. Vioquest Pharmaceutl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.Things to note about VioQuest Pharmaceuticals performance evaluation
Checking the ongoing alerts about VioQuest Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for VioQuest Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VioQuest Pharmaceuticals is not yet fully synchronised with the market data | |
| VioQuest Pharmaceuticals has some characteristics of a very speculative penny stock | |
| VioQuest Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.41, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist VioQuest Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, VioQuest Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VioQuest Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VioQuest to invest in growth at high rates of return. When we think about VioQuest Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (10.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| VioQuest Pharmaceuticals currently holds about 814.48 K in cash with (7.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing VioQuest Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VioQuest Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining VioQuest Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VioQuest Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of VioQuest Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VioQuest Pharmaceuticals' pink sheet. These opinions can provide insight into VioQuest Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in VioQuest Pink Sheet
If you are still planning to invest in VioQuest Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VioQuest Pharmaceuticals' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets |